Gf Fund Management Co. Ltd. Uro Gen Pharma Ltd. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,080 shares of URGN stock, worth $14,731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,080
Previous 886
21.9%
Holding current value
$14,731
Previous $9.44 Million
26.59%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$59.5 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$52.3 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$43.7 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$31.4 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$29.9 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $310M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...